ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,517.76
-0.59%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. ImmunoGen Inc (IMGN)

  7. ImmunoGen Inc (IMGN) Noticias

IMGN

ImmunoGen (IMGN)

ImmunoGen Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:IMGN
FechaHoraFuenteTítuloSímboloCompañía
22/02/202415:15Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:IMGNImmunoGen Inc
14/02/202416:01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IMGNImmunoGen Inc
12/02/202415:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMGNImmunoGen Inc
12/02/202415:33Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:IMGNImmunoGen Inc
12/02/202408:32Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:IMGNImmunoGen Inc
12/02/202406:52Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMGNImmunoGen Inc
12/02/202406:37PR Newswire (US)AbbVie Completes Acquisition of ImmunoGenNASDAQ:IMGNImmunoGen Inc
05/02/202415:10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IMGNImmunoGen Inc
01/02/202415:30Business WireImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IMGNImmunoGen Inc
29/01/202416:01Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:IMGNImmunoGen Inc
12/01/202410:10PR Newswire (US)Kuehn Law Encourages PXD, IMGN, HA and ICVX Investors to Contact Law FirmNASDAQ:IMGNImmunoGen Inc
02/01/202417:10PR Newswire (US)Kuehn Law Encourages CERE, HA, IMGN, and WAVD Investors to Contact Law FirmNASDAQ:IMGNImmunoGen Inc
02/01/202415:26Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:IMGNImmunoGen Inc
21/12/202315:52Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNASDAQ:IMGNImmunoGen Inc
19/12/202318:00Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:IMGNImmunoGen Inc
10/12/202311:00Business WireImmunoGen Presents Findings from Newly Diagnosed Acute Myeloid Leukemia Cohorts in Phase 1b/2 Study of Pivekimab Sunirine in Combination with Azacitidine and Venetoclax at ASHNASDAQ:IMGNImmunoGen Inc
08/12/202305:23IH Market NewsApple Boosts Vietnam Production, Broadcom Revenue Miss, Stellantis Job Cuts – Latest UpdatesNASDAQ:IMGNImmunoGen Inc
05/12/202306:46Dow Jones NewsImmunogen Gets FDA Priority Review of Elahere Full ApprovalNASDAQ:IMGNImmunoGen Inc
30/11/202307:42Dow Jones NewsImmunoGen Shares Soar Premarket on Takeover by AbbVieNASDAQ:IMGNImmunoGen Inc
30/11/202307:13Dow Jones NewsAbbVie to Buy ImmunoGen for More Than $10 BillionNASDAQ:IMGNImmunoGen Inc
30/11/202306:30PR Newswire (US)AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor PortfolioNASDAQ:IMGNImmunoGen Inc
02/11/202315:30Business WireImmunoGen Announces Webcast of Presentation and Q&A at Upcoming Jefferies London Healthcare ConferenceNASDAQ:IMGNImmunoGen Inc
02/11/202315:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IMGNImmunoGen Inc
02/11/202305:30Business WireImmunoGen Reports Recent Progress and Third Quarter 2023 Financial ResultsNASDAQ:IMGNImmunoGen Inc
27/10/202305:30Business WireImmunoGen Announces European Medicines Agency Acceptance of Marketing Authorization Application for Mirvetuximab Soravtansine in Platinum-Resistant Ovarian CancerNASDAQ:IMGNImmunoGen Inc
23/10/202307:30PR Newswire (US)Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory BoardNASDAQ:IMGNImmunoGen Inc
19/10/202315:01Business WireImmunoGen Announces Conference Call to Discuss Its Third Quarter 2023 Operating ResultsNASDAQ:IMGNImmunoGen Inc
28/09/202306:00Business WireELAHERE® Shows Overall and Progression-Free Survival Benefit Regardless of Prior PARPi Exposure or Prior Lines of Therapy in FRα-Positive Platinum-Resistant Ovarian CancerNASDAQ:IMGNImmunoGen Inc
19/09/202316:37Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IMGNImmunoGen Inc
18/09/202305:30Business WireImmunoGen Appoints Lauren White as Senior Vice President and Chief Financial OfficerNASDAQ:IMGNImmunoGen Inc
 Showing the most relevant articles for your search:NASDAQ:IMGN

Su Consulta Reciente

NYSE
XOM
Exxon Mobil
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
AMZN
Amazon.com
CCOM
OILBRENT
Brent Oil
NYSE
MRK
Merck
NYSE
JPM
JP Morgan Chase
USOTC
RHHBY
Roche (QX)
USI
USTECH100
US Tech 100
NYSE
VZ
Verizon Communications
USOTC
BNPQY
BNP Paribas (QX)
AMEX
XLE
Energy Select Sector SPDR
COIN
ETHUSD
Ethereum
USOTC
BASFY
BASF (QX)
NYSE
MCD
McDonalds
NASDAQ
TSLA
Tesla
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados